Overview
Davi Aragon practices in Ribeirao Preto, Brazil. Aragon is rated as an Experienced expert by MediFind in the treatment of Pulmonary Edema. Their top areas of expertise are Angioedema, Necrotizing Enterocolitis, Hereditary Angioedema, and Atopic Dermatitis.
Their clinical research consists of co-authoring 96 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Pulmonary Edema.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- AngioedemaAragon isAdvanced. Learn about Angioedema.
- Atopic DermatitisAragon isAdvanced. Learn about Atopic Dermatitis.
- Hereditary AngioedemaAragon isAdvanced. Learn about Hereditary Angioedema.
- HivesAragon isAdvanced. Learn about Hives.
- Necrotizing EnterocolitisAragon isAdvanced. Learn about Necrotizing Enterocolitis.
- Premature InfantAragon isAdvanced. Learn about Premature Infant.
- Experienced
- AscariasisAragon isExperienced. Learn about Ascariasis.
- Asphyxia NeonatorumAragon isExperienced. Learn about Asphyxia Neonatorum.
- AsthmaAragon isExperienced. Learn about Asthma.
- Chronic Familial NeutropeniaAragon isExperienced. Learn about Chronic Familial Neutropenia.
- Congenital Heart Disease (CHD)Aragon isExperienced. Learn about Congenital Heart Disease (CHD).
- COVID-19Aragon isExperienced. Learn about COVID-19.